A neutral red assay involving Vero cells was used to quantitate the cytotoxic activity of verotoxins (VT) produced by Escherichia coli and to investigate changes in titer caused by altering the composition of the cell culture medium. Three variations on medium 199 were investigated: one involved supplementing the medium with 5% fetal bovine serum (FBS), a second was the use of serum-free (SF) medium that contained 5% bovine serum albumin and 5 ,ug of fibronectin per ml, and the third involved the use of 4% Ultroser G, a commercial serum replacement. The level of cytotoxicity varied markedly with the type of VT and with the medium that was used. For VT1, there was no difference in cytotoxicity between medium with 5% FBS and SF medium, but cytotoxicity was reduced more than 100-fold in medium containing Ultroser G compared with cytotoxicity in the other media. For VT2, VT2v, and VTe, there was a slight reduction in cytotoxicity in medium containing 4% Ultroser G and a more marked reduction in SF medium compared with cytotoxicity in medium containing 5% FBS.
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The Vero cell assay (VCA) has been widely used to assess the cytotoxicity of verotoxin-producing Escherichia coli (VTEC) strains (7) . One of the major components of the tissue culture medium is fetal bovine serum (FBS) . The efficacy of the VCA may be affected by the presence of contaminating bovine antibodies in FBS, thus creating variability between lots which could interfere with the quantification of cytotoxicity. In addition, variations in the glycolipid content of different lots of FBS (9) may result in various degrees of competition with verotoxins (VT) for binding to specific receptor sites on Vero cells.
The neutral red assay (NRA) has been used extensively for in vitro assessment of cytotoxicity of infectious agents (5, 16) , food additives, and pharmaceuticals (1) . In this study, we evaluated the use of the NRA for quantification of cytotoxicity in Vero cells and assessed the influence of the serum component of tissue culture medium on the VCA.
The VTEC strains used in this study are listed in Table 1 . E. coli strains were grown overnight at 37°C in 2 ml of brain heart infusion broth (Difco, Detroit, Mich.); then 100 ,ul of culture was transferred into 1 ml of brain heart infusion, incubated for 6 h, and centrifuged. The culture supernatant was filtered through a 0.45-,um-pore-size membrane filter and tested for cytotoxic activity. Purified VT1 was provided by C. A. Lingwood, Hospital for Sick Children, Toronto, Ontario, Canada. The extraction and purification of VTe have been described elsewhere (10 In order to visualize the interaction between the toxins and UG, purified VT1 and VTe were immobilized on a 0.2-,um-pore-size nitrocellulose membrane (NCM) by the Easy-Titer enzyme-linked immunofiltration assay system (Pierce, Rockford, Ill.). The membrane was then cut into strips and blocked with phosphate-buffered saline (PBS) containing 0.3% Tween 20 (PBSTW) at 37°C for 1 h. The NCM strips were rocked continuously throughout this step and subsequent steps of the assay. UG (4%), ammonium sulfate-treated UG, and polyclonal antibodies to purified VT1 and VTe (1:100), raised in pigs, were added, and the mixture was incubated at 4°C overnight. The NCM strips were washed in PBSTW five times (4 min each), and alkaline phosphatase-conjugated antibody (1:1,000) was added and allowed to react for 2 h at room temperature. The NCM strips were again washed with PBSTW five times (4 min each) and then twice with PBS (1 min each) and once with substrate buffer for 4 min. Substrate (5-chromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium [BCIP-NBT]) was added, and the reaction was stopped after 10 min or when strong color developed.
To determine binding of VT1 and VTe to FN and BSA, the following procedure was applied. BSA and FN were immobilized on 0.2-pum-pore-size NCM by the ELIFA system. Strips were cut, blocked with PBSTW at 37°C for 1 h, and exposed to purified VT1 and VTe overnight at 4°C. Porcine anti-VT1 and anti-VTe (1:100) were used as primary antibodies with the corresponding alkaline phosphatase conjugate by the protocol outlined in the previous paragraph.
The 50% tissue culture cytotoxic doses (TCCD50s) for three replicates were calculated (5, 16) was established by the method of Rovozzo and Burke (11) , adjusting the proportionate distance to the log base 5 and converting to log base 10. Analysis of variance was performed, and Duncan's multiple range test (13) was used to determine whether significant differences existed among the three medium formulations (P = 0.05).
When the medium containing UG was used, the supernatants from VT1-producing strains of VTEC had a reduced TCCD50 compared with titers obtained with cells grown in SF and FBS media ( (Fig. 1) . Immobilization of purified VT1 on NCM and subsequent application of UG as a primary antibody gave a positive signal with alkaline phosphatase-conjugated goat anti-bovine immunoglobulin G (Fig. 2) . For VT1, there were no significant differences in the TCCD50 levels measured for SF and FBS media. In contrast, for the VT2 subgroup of toxins (VT2, VT2v, and VTe), there was significant inhibition of cytotoxicity (P = 0.05) with SF medium compared with that for FBS medium ( Previous studies have established that VT1-neutralizing antibodies are prevalent in the cattle population (2) , and since UG is an undefined product of bovine origin, it is possible that the serum content in it is high. When UG was subjected to ammonium sulfate treatment, there was a 1.78 log increase of cytotoxicity for VT1, suggesting that the low cytotoxicity level might have been due to specific antibodies. The dot immunoblot analysis confirmed the inhibiting factor in UG as bovine immunoglobulins, since the conjugate is an enzyme-labelled affinity-purified antibody that specifically recognizes bovine immunoglobulin G.
Naturally occurring antibodies against glycolipids containing the Galal-4GalI3 sequence (Forssmann and Tja antibodies) have been described previously (8, 9) . The functional glycolipid receptor for both VT1 and VT2 (9, 17) is globotriaosylceramide. It is therefore unlikely that antiglycolipid antibodies were mediating this effect, since there was no corresponding decrease in VT2 cytotoxicity.
There were no significant differences in the TCCD50 levels measured for SF and FBS media for VT1. However, in the VT2 subgroup of toxins (VT2, VT2v, and VTe), significant inhibition of cytotoxicity was observed (P = 0.05) with SF medium (Table 1 ). This could be attributed to the BSA and/or FN present in the medium. FN was included in the SF medium to promote cell attachment, but it is known to bind proteins (12) . However, the fact that neither BSA nor FN bound to purified VT1 or VTe suggests that binding of toxin to these components was not the factor responsible for the decrease in titer. Furthermore, since the VT2 subgroup is a heterogeneous cluster with different binding specificities (6, 14) , it is unlikely that specific binding was a factor.
When used with appropriate control strains, the NRA allowed quantitative assessment of cytotoxicity and detection of interfering substances among different medium formulations. In this study, neither UG nor SF proved to be a satisfactory replacement for FBS in the VCA. The NRA has also been successfully used with endothelial cells and LS180 human adenocarcinoma cells to assess cytotoxicity of VT (15) .
The NRA proved to be a valuable quantitative tool and provides a useful adjunct to the routine VCA. The VCA using the NRA modification will allow factors that play a role in diseases caused by VTEC to be dissected in a more systematic manner.
